DCN Dx to Showcase New Technologies at NextGen Dx 2024
DCN Dx, a leading global provider of IVD CDMO and CRO services, announces its participation in the NextGen Dx Summit 2024, held from August 19-21 at the Walter E. Washington Convention Center…
FDA Grants HemoSonics Expanded Use of its Critical Bleeding Management System with Special 510(k) Clearance
HemoSonics, a medical device company focused on acute bleeding management, today announced it has received Special 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the expanded use…
